Mendelian
London
About Mendelian
Mendelian is helping doctors diagnose rare genetic diseases faster. Mendelian uses patient’s clinical features to find genes responsible for rare diseases. Mendelian's intelligent agent parses patient's phenotypic features entered by a physician and outputs their causative genes and mutations. Thus offering a new way of investigating undiagnosed cases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.4M
- Last round: Grant (Mar 2023)
- Website: mendelian.co
- Phone: [email protected]
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/mendelian-60854 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.